Profile | GDS4284 / 230986_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3900.65 | 91 |
GSM687648 | Patient 402 control | 617.093 | 67 |
GSM687653 | Patient 403 control | 3574.21 | 90 |
GSM687658 | Patient 404 control | 2038.24 | 84 |
GSM687663 | Patient 411 control | 4624.57 | 93 |
GSM687668 | Patient 422 control | 6183.78 | 95 |
GSM687673 | Patient 424 control | 2773.46 | 88 |
GSM687678 | Patient 425 control | 2059.13 | 84 |
GSM687683 | Patient 427 control | 2844.69 | 88 |
GSM687688 | Patient 428 control | 4677.92 | 93 |
GSM687695 | Patient 441 control | 348.868 | 53 |
GSM687699 | Patient 443 control | 3913.71 | 92 |
GSM687704 | Patient 444 control | 3244.62 | 89 |
GSM687707 | Patient 448 control | 4089.75 | 92 |
GSM687712 | Patient 449 control | 2882.27 | 88 |
GSM687719 | Patient 450 control | 2610.05 | 87 |
GSM687724 | Patient 451 control | 2734 | 88 |
GSM687728 | Patient 452 control | 3328.54 | 90 |
GSM687646 | Patient 401 treated 24h | 4787.35 | 93 |
GSM687649 | Patient 402 treated 24h | 670.66 | 68 |
GSM687665 | Patient 411 treated 24h | 3315.97 | 90 |
GSM687651 | Patient 402 treated 4 weeks | 597.067 | 66 |
GSM687667 | Patient 411 treated 4 weeks | 5020 | 93 |
GSM687670 | Patient 422 treated 24h | 7013.05 | 96 |
GSM687671 | Patient 422 treated 4 weeks | 7097.11 | 96 |
GSM687654 | Patient 403 treated 24h | 3433.84 | 90 |
GSM687675 | Patient 424 treated 24h | 2533.61 | 87 |
GSM687685 | Patient 427 treated 24h | 1793.29 | 82 |
GSM687656 | Patient 403 treated 4 weeks | 2302.02 | 85 |
GSM687677 | Patient 424 treated 4 weeks | 3026.26 | 89 |
GSM687687 | Patient 427 treated 4 weeks | 3150.85 | 89 |
GSM687692 | Patient 428 treated 4h | 7002.18 | 95 |
GSM687716 | Patient 449 treated 4h | 2350.43 | 86 |
GSM687722 | Patient 450 treated 4h | 2342.24 | 86 |
GSM687680 | Patient 425 treated 24h | 1735.29 | 82 |
GSM687690 | Patient 428 treated 24h | 6852.26 | 95 |
GSM687700 | Patient 443 treated 24h | 1828.66 | 83 |
GSM687705 | Patient 444 treated 24h | 1903.77 | 83 |
GSM687714 | Patient 449 treated 24h | 2613.62 | 87 |
GSM687721 | Patient 450 treated 24h | 1595.16 | 81 |
GSM687682 | Patient 425 treated 4 weeks | 1425.12 | 79 |
GSM687694 | Patient 428 treated 4 weeks | 4909.43 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 3638.11 | 91 |
GSM687718 | Patient 449 treated 4 weeks | 2312.05 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 2644.99 | 87 |
GSM687661 | Patient 404 treated 4h | 1852.34 | 83 |
GSM687710 | Patient 448 treated 4h | 3383.88 | 90 |
GSM687726 | Patient 451 treated 4h | 3024.84 | 89 |
GSM687730 | Patient 452 treated 4h | 2948.53 | 90 |
GSM687660 | Patient 404 treated 24h | 641.937 | 69 |
GSM687697 | Patient 441 treated 24h | 446.415 | 60 |
GSM687709 | Patient 448 treated 24h | 3865.76 | 91 |
GSM687725 | Patient 451 treated 24h | 2250.69 | 86 |
GSM687729 | Patient 452 treated 24h | 1497.4 | 82 |
GSM687727 | Patient 451 treated 4 weeks | 1682.56 | 82 |
GSM687731 | Patient 452 treated 4 weeks | 1934.31 | 83 |